DNA-damaging agents are commonly used to target cancer cells thereby killing them and causing cancer remission.
Cancer
Researchers have identified three molecules that offer a promising solution that can prevent cancer relapse during treatment, according to a new study. The study focused on colon cancer as a model system and involved physically screening a large library of approved drugs or small molecules to identify these promising compounds.